Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Tositumomab

EU orphan designation number: EU/3/03/137   
Active ingredient: Tositumomab
Indication: Treatment of follicular lymphoma
Sponsor: GlaxoSmithKline Research & Development Limited
1-3 Iron Bridge Road, Stockley Park West, Uxbridge, Middlesex UB11 1BT, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/02/2003 Centralised Orphan - Designation EMEA/OD/079/02 (2003)590 of 14/02/2003
12/08/2005 Centralised Orphan - Transfer of orphan designation EMEA/OD/079/02/T/01 (2005)3178 of 10/08/2005
30/05/2011 Other procedure EMEA/OD/079/02